# Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions

> **NCT02110368** · PHASE3 · COMPLETED · sponsor: **Amneal Pharmaceuticals, LLC** · enrollment: 32 (actual)

## Conditions studied

- Primary Hypogonadism
- Hypogonadotropic Hypogonadism

## Interventions

- **DRUG:** Testosterone Topical Gel, 1.62% Metered Pump
- **DRUG:** AndroGel (testosterone gel) 1.62% Metered-Dose Pump

## Key facts

- **NCT ID:** NCT02110368
- **Lead sponsor:** Amneal Pharmaceuticals, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-05
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2014-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02110368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02110368, "Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02110368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*